Ori has developed a proprietary, flexible manufacturing platform that closes, automates and standardises cell and gene therapy (CGT) manufacturing, allowing therapeutics developers to further develop and bring their products to market at commercial scale. The promise of the full stack Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining hardware, software and data services. Ori was founded by Professor Chris Mason (AVRO) and Dr. Farlan Vera itch (UCL) and has brought together a seasoned Board and executive management team with over 80 years of pharmaceutical, CGT and venture building experience including Chairman Barry Clare (BHI), CEO Jason C. Foster (lndivior) and CBO Jason Jones (Miltenyi Biotec) along with expert advisers like Bruce Levine, Anthony Davies and Annalisa Jenkins.